OncoTherapy Science, Inc. (TYO:4564)
27.00
-2.00 (-6.90%)
Apr 17, 2026, 3:30 PM JST
OncoTherapy Science Market Cap
OncoTherapy Science has a market cap or net worth of 10.36 billion as of April 17, 2026. Its market cap has increased by 36.19% in one year.
Market Cap
10.36B
Enterprise Value
8.17B
Revenue
784.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.00
Market Cap Chart
Since June 29, 2007, OncoTherapy Science's market cap has decreased from 13.84B to 10.36B, a decrease of -25.17%. That is a compound annual growth rate of -1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 10.36B | 50.71% |
| Dec 30, 2025 | 6.87B | 1.20% |
| Dec 30, 2024 | 6.79B | 35.66% |
| Dec 29, 2023 | 5.01B | -50.03% |
| Dec 30, 2022 | 10.02B | -27.78% |
| Dec 30, 2021 | 13.87B | -31.60% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 14.06B |
| Kidswell Bio | 12.40B |
| Nano Holdings | 12.06B |
| CellSeed | 11.47B |
| Kubota Pharmaceutical Holdings | 11.19B |
| K Pharma,Inc. | 8.80B |
| BrightPath Biotherapeutics | 8.78B |
| StemCell Institute | 8.03B |